Fecal microbiota and bile acids in IBD patients undergoing screening for colorectal cancerAonghus Lavelle, Harry Sokol, Philippe Marteau et al.|Gut Microbes|2022Cited by 59
The IBD-disk Is a Reliable Tool to Assess the Daily-life Burden of Patients with Inflammatory Bowel DiseaseSara Tadbiri, Émilie Del Tedesco, Maria Nachury et al.|Journal of Crohn s and Colitis|2020Cited by 35
Adalimumab in Biologic-naïve Patients With Crohn’s Disease After Resolution of an Intra-abdominal Abscess: A Prospective Study From the GETAIDYoram Bouhnik, Claire Painchart, Guillaume Pineton de Chambrun et al.|Clinical Gastroenterology and Hepatology|2023Cited by 23
Prevalence and Determinants of Fatigue in Patients with IBD: A Cross-Sectional Survey from the GETAIDAurélien Amiot, Virginie Cluzeau, Sayma Chaibi et al.|Journal of Crohn s and Colitis|2023Cited by 20
Management of immune checkpoint inhibitor in patients with cancer and pre-existing inflammatory bowel disease: Recommendations from the GETAIDAurélien Amiot, Pauline Wils, David Laharie et al.|Digestive and Liver Disease|2022Cited by 12